RAPT vs TMUS · $132.1M cap vs P/E 19, rev $22.79B
RAPT Therapeutics Inc (RAPT) versus T-Mobile US Inc (TMUS) — a side-by-side from cached financials, not a winner call.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
T-Mobile US Inc (TMUS) is a telecom services company listed on NASDAQ. It is led by Mike Sievert.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
Latest reported TMUS revenue for 2026-06-30 was $22.79B. Net income was $3.24B. Revenue was down 1.4% from 2026-03-31 to 2026-06-30. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
RAPT currently screens at market cap $132.1M. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
Not investment advice. Open the RAPT and TMUS stock pages for the full models.
Not investment advice.